Listed

Chemed Corp: Form 10-Q for the period ended Sep 30, 2019

Filed with the SEC on Nov 4, 2019 and accepted by EDGAR at Nov 4, 2019, 08:32 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-07-01 to 2019-09-30$480.6mus-gaap:Revenues
Revenue9 months2019-01-01 to 2019-09-30$1.42bnus-gaap:Revenues
Cost of revenue3 months2019-07-01 to 2019-09-30$328.2mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2019-01-01 to 2019-09-30$973.8mus-gaap:CostOfGoodsAndServicesSold
Selling, general and administrative3 months2019-07-01 to 2019-09-30$76.8mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2019-01-01 to 2019-09-30$222.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2019-07-01 to 2019-09-30$64.9mus-gaap:OperatingIncomeLoss
Operating income9 months2019-01-01 to 2019-09-30$179.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2019-07-01 to 2019-09-30$1.0mus-gaap:InterestExpense
Interest expense9 months2019-01-01 to 2019-09-30$3.4mus-gaap:InterestExpense
Income tax3 months2019-07-01 to 2019-09-30$8.0mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2019-01-01 to 2019-09-30$27.7mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-07-01 to 2019-09-30$58.9mus-gaap:NetIncomeLoss
Net income9 months2019-01-01 to 2019-09-30$154.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-07-01 to 2019-09-30$3.56us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2019-01-01 to 2019-09-30$9.35us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-07-01 to 2019-09-30$3.69us-gaap:EarningsPerShareBasic
Basic EPS9 months2019-01-01 to 2019-09-30$9.68us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2019-07-01 to 2019-09-3016,555,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2019-01-01 to 2019-09-3016,514,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2019-01-01 to 2019-09-30$237.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2019-01-01 to 2019-09-30$39.8mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2019-01-01 to 2019-09-30$14.7mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases9 months2019-01-01 to 2019-09-30$71.9mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2019-09-30$9.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-09-30$167.8mus-gaap:AssetsCurrent
Total assetsAt period end2019-09-30$1.23bnus-gaap:Assets
Current liabilitiesAt period end2019-09-30$251.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-09-30$560.2mus-gaap:Liabilities
Long-term debtAt period end2019-09-30$130.0mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2019-09-30$672.4mus-gaap:StockholdersEquity
Shares outstandingAt period end2019-09-3016,009,258 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0000019584-19-000016. Last ingested by Listed: Nov 14, 2026, 12:29 ET. Listed shows no prices and gives no investment advice.